1 / 41

CD4 for monitoring HIV Progression

CD4 for monitoring HIV Progression. 31 st Annual National Conference of Indian Association of Preventive & Social Medicine, 27 th – 29 th Feb 2004 PGIMER, Chandigarh Dr. Arvinder Singh BD Biosciences. China -CDC -MOH -BDB. BD Bio-IS - Value Proposition

agalia
Download Presentation

CD4 for monitoring HIV Progression

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CD4 for monitoring HIV Progression 31st Annual National Conference of Indian Association of Preventive & Social Medicine, 27th – 29th Feb 2004 PGIMER, Chandigarh Dr. Arvinder Singh BD Biosciences

  2. China -CDC -MOH -BDB BD Bio-IS -Value Proposition -Education and training -QC/QA protocols -Application protocols -Reference range studies India -ICMR -NACO -Hospitals / Path labs -BDB Africa -WHO -Countries -DOD -NGOs -BDB Thailand -MOH -COE -BDB Other Countries -WHO -NGOs -BDB GOVT -NIH -WHO -HRF -UNAID -DOD -USAID NGOs -AAACP -MSF -IAVI -WJCF -HVTN -AMFAR -JHU -GMHC BD Activities Brazil -COOPEX -MOH -BDB

  3. HIV/AIDSWhat is CD4/CD8

  4. Flow Cytometry Clinical Applications • HIV immunophenotyping (CD4 absolute counts) • Cytokine analysis • Leukemia and lymphoma diagnosis - minimum residual disease detection • Cell cycle and DNA ploidy analysis • Stem Cell Analysis • HLA – B 27 Typing • Residual white blood cell detection • Reticulocyte enumeration • Flow crossmatching (organ transplantation)

  5. What Is Flow Cytometry? A technology that simultaneously measures multiple characteristics of single cells at a rapid rate

  6. 1000 800 600 400 200 0 0 200 400 600 800 1000 Lysed Whole Blood Neutrophils Side Scatter Monocytes Lymphocytes Forward Light Scatter

  7. Two-Color Cell Analysis 104 10 3 CD8 PE 10 2 101 10 0 100 101 102 103 10 4 CD4 FITC

  8. Fourcolor analysis CD8 PE SSC Height CD45 PerCP CD3 FITC CD8 PE CD4 Cy5 CD3 FITC CD4 Cy5

  9. 42 Million People Living with AIDS

  10. India – Current Situation HIV • HIV prevalence rate is 0.7% • India has had a sharp increase in the estimated number of HIV infections, from a few thousand in the early 1990s to a working estimate of about 3.8 million children and adults living with HIV/AIDS in 2001 • Estimates range from 8 - 15 million HIV infected adults and children living with HIV in 2010 • Given India's large population, a mere 0.1 percent increase in the prevalence rate would increase the number of adults living with HIV/AIDS by over half a million people

  11. India – Current Situation HIV • About 90% of the total reported AIDS cases occur in the sexually active and economically productive 15 to 44 age group • Men account for 79% of HIV infections in India • The predominant mode of HIV transmission is through heterosexual contact • In 2001, the HIV infection rate went above one per cent in six states • Maharashtra, Tamil Nadu and Manipur - account for 75% of estimated HIV cases • the burden of AIDS cases is beginning to be felt in states affected early - Mumbai and Manipur have recorded 20 to 49 per cent bed occupancy by HIV positive people in certain hospitals

  12. HIV/AIDS Pandemic Disease Management Vaccines, Drugs, Education • Antiretroviral Therapy (ART) Controls disease progression Increasing drug resistance patterns Expensive (Big Pharma – western countries) Trend to affordable (generic) drugs in developing world • CD4 T-Lymphocyte Count Flow cytometry is gold standard Alternate technologies – currently inadequate FacsCount is considered system of choice CD4 count is the single most important objective criteria to guide clinical decision-making on when to use ART

  13. HIV Testing paradigm Screen Confirm* CD4 Viral load Est. annual tests 15-20M 4-6M 5-8M 1-2M *(includes genotyping)

  14. PCR Viral load It is a technique that imitates a cell’s ability to replicate DNA by generating multiple copies of specific sequences of DNA through amplification. In clinical diagnostics, a specimen of genetic material can be repeatedly copied by PCR to provide sufficient material to detect the presence or absence of a virus as well as to quantitate its levels in the blood. It’s used for: • The development of new drugs • To establish a patient’s disease status and the likelihood of disease progression • To determine when to start treatment • To help the physician decide which drugs to use in a treatment regimen • To assess whether a treatment regimen is working

  15. CD4 and viral load

  16. HIV/AIDS Pandemic Situational Analysis Unmet Needs • Affordable drugs/ART •   Affordable CD4

  17. Flow Cytometry GOLD STANDARD FOR CD4/CD8 Monitoring in HIV/AIDS Patients Conceptually established by BD Worldwide

  18. FACSCount - Complete SystemIVD approved ( US FDA )

  19. FACSCount - Complete System Premeasured Reagents

  20. FACSCount - Complete System FACSCount Reagents and Controls FACSCount Workstation

  21. FACSCount Measuring Absolute CD4, CD8 and CD3 Counts In Three Easy Steps

  22. FACSCount - Clinical Need • Safety • Minimal Sample Preparation • Fixed Samples • Absolute Counts • Limited Handling of • Biohazardous Samples

  23. FACSCount - Clinical Need • Easy to use • Absolute Counts • Unit Dose Reagents • Minimal Hands-On Time • No Formal Training Required

  24. FACSCounts in India • 35 Placements • 23 Instruments through NACO • 12 Instruments in Private Path Laboratories

  25. MALES CD3+ 617 – 2485 CD19+ 125 – 701 CD4+ 337 – 1090 CD8+ 174 – 1240 Ratio 0.61 – 2.68 HIV Patients-Low CD4 FEMALES CD3+ 898 – 2786 CD19+ 119 – 721 CD4+ 424 – 1050 CD8+ 255 – 1353 Ratio 0.95 – 2.40 Reference Range of Lymphocytes Subsets In Healthy Individuals (India)

  26. FACSCount - Analysis • A hard copy results • The control • Patient sample

  27. HIV Monitoring BD provides a gold standard system of reliable products and support services for CD4+ T-cell testing at affordable pricing. • Appropriate Technology • Flow Cytometry • Capacity Building • Training, Support, Service • Reliable Laboratory Systems • GMP/GLP (IVDP)/GCP

  28. Performance of Competitive Tests

  29. Pharmas taking action • Abbott Laboratories • Bristol-Meyers Squibb • GlaxoSmithKline • Hoffmann La-Roche Ltd • Boehringer Ingelheim • Merck & Co., Inc • Pfizer • Cipla • Ranbaxy • Matrix

  30. General concensus is that flow cytometry based CD4 count is the most accepted technique to HIV monitoring • Quantitative – more cells counted, more reliable result • Specific – mAb, identify CD4 T-lymphocytes most precisely • QA/QC – internal and external - necessary for accreditation • Throughput – manual operation is acceptable as technician costs are not significant and does not limit test demand • Existing flow cytometry systems (FACSCalibur or similar) are adequate/accepted for Central Reference facilities – usually at the sites of principal government services • Perform broad clinical testing plus Research studies associated with international partners • Affordable lower cost platform required at Provincial and Local clinic sites – dedicated clinical test platform • Capability to perform CD4 count ( - ideal with broader test menu ) • Current FACSCount system should be viewed as maximal technology complexity – sample preparation potential issue – reagent cost limitation • Challenge from Partec / Guava like technology or alternative assays

  31. Application Comparison

  32. Affordable Testing for HIV/AIDS in the Developing WorldFebruary 5, 2004 On January 14, 2004, the William J. Clinton Presidential Foundation announced that BD, through BD Biosciences, had entered into an agreement with the Foundation to provide affordable CD4 testing, both reagents and instruments, to the poorest and most severely HIV/AIDS afflicted areas in the developing world. The CD4 immunocytometry test has been used to establish decision points for antiretroviral (ARV) therapy, to monitor efficacy of various treatments, as a prognostic indicator, and as one criterion for initiating prophylaxis for opportunistic infections. The viral load test helps measure how effective ARV therapies are in suppressing the virus and can alert clinicians about the need to adjust dosages or change regimens.

  33. BD BiosciencesAccomplishing our Mission – HIV/AIDS BD Biosciences is Helping With the Global AIDS Crisis by: • Supporting the Brazilian AIDS prevention program • Example program for reducing mortality and new infections in the developing world • Our flow instruments and reagents are used as the gold standard to monitor disease progression in HIV-infected individuals • Collaborating with the International AIDS Vaccine Initiative (IAVI) • Speed the development and distribution of preventive AIDS vaccines • Our flow instruments and reagents are used to detect immune response to the vaccine

  34. HIV/AIDS PANDEMIC 2010 80+ million PLWHA India (15+ million) China (15+ million) Negative growth rates in most of Africa due to AIDS mortality WW economic impact 2002 Brazil Achieves 50% reduction in AIDS deaths over last 10 years Accessible drugs and health care $500,000 million savings on AIDS impact

More Related